The inhibition of long-chain fatty acyl-CoA synthetase by enoximone in rat heart mitochondria

J Cardiovasc Pharmacol. 1992 Jun;19(6):899-904. doi: 10.1097/00005344-199206000-00009.

Abstract

The mechanism by which enoximone, a reported phosphodiesterase inhibitor, inhibits the oxidation of long-chain fatty acids was studied in isolated rat heart mitochondria using a series of 14C-labeled substrates. Enoximone decreased palmitate oxidation in a time- and concentration-dependent manner. Fifty percent inhibition of palmitate oxidation was achieved with 250 microM of enoximone. In contrast to its effect on palmitate, enoximone (250 microM) increased octanoate oxidation by 30%, whereas pyruvate oxidation was unaffected by enoximone. At that dose there was no effect on the oxidation of palmitoyl-CoA and palmitoyl carnitine. The degree of palmitate oxidation inhibited by enoximone was parallel to the inhibition of acyl-CoA synthetase in both rat heart mitochondria and microsomes. These results suggest that enoximone is a reversible inhibitor of long-chain fatty acyl-CoA synthetase. Moreover, the reaction, which is catalyzed by this enzyme, is a rate-limiting step in the pathway of fatty acid oxidation in rat heart mitochondria.

MeSH terms

  • Acyl Coenzyme A / antagonists & inhibitors*
  • Animals
  • Coenzyme A Ligases / antagonists & inhibitors*
  • Enoximone
  • Imidazoles / pharmacology*
  • In Vitro Techniques
  • Kinetics
  • Male
  • Microsomes / drug effects
  • Microsomes / enzymology
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / enzymology*
  • Myocardium / cytology
  • Myocardium / metabolism
  • Oxidation-Reduction
  • Oxygen Consumption / drug effects
  • Rats
  • Rats, Inbred Strains

Substances

  • Acyl Coenzyme A
  • Imidazoles
  • Enoximone
  • Coenzyme A Ligases